Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis

PURPOSE: To evaluate the effect of the 21-gene recurrence score (RS) assay in breast cancer-specific mortality (BCSM) and decision-making for chemotherapy in older (aged ≥65 years) breast cancer. METHODS: We retrospectively included older patients with T1-2N0 and estrogen receptor-positive breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ping, Zhang, Wen-Wen, Bao, Yong, Wang, Jun, Lian, Chen-Lu, He, Zhen-Yu, Wu, San-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718160/
https://www.ncbi.nlm.nih.gov/pubmed/33278648
http://dx.doi.org/10.1016/j.breast.2020.11.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718160/
https://www.ncbi.nlm.nih.gov/pubmed/33278648
http://dx.doi.org/10.1016/j.breast.2020.11.018

Ejemplares similares